Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Titel:
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Auteur:
Berger, Jeffrey S. Bhatt, Deepak L. Steg, P. Gabriel Steinhubl, Steven R. Montalescot, Gilles Shao, Mingyuan Hacke, Werner Fox, Keith A. Berger, Peter B. Topol, Eric J. Lincoff, A. Michael